[Treatment of HHV-6 and HHV-7 infections].
Moriuchi
Masako
M
Division of Medical Virology, Department of Molecular Microbiology and Immunology, Nagasaki University Graduate School of Biomedical Sciences.
Moriuchi
Hiroyuki
H
D000998:Antiviral Agents / Q000008:administration & dosage*; D000077404:Cidofovir; D003596:Cytosine / Q000008:administration & dosage / Q000031:analogs & derivatives; D004359:Drug Therapy, Combination; D017245:Foscarnet / Q000008:administration & dosage*; D015774:Ganciclovir / Q000008:administration & dosage*; D015654:Herpesvirus 6, Human; D016199:Herpesvirus 7, Human; D006801:Humans; D007136:Immunoglobulins / Q000008:administration & dosage; D017710:Lymphocyte Transfusion; D063065:Organophosphonates / Q000008:administration & dosage; D019349:Roseolovirus Infections / Q000628:therapy* / Q000821:virology
D000998:Antiviral Agents; D007136:Immunoglobulins; D063065:Organophosphonates; D017245:Foscarnet; D003596:Cytosine; D000077404:Cidofovir; D015774:Ganciclovir